Abstract: An embodiment is a sealing assembly for a twin swing gate of a vehicle, the sealing assembly including a first gate of which an outside end portion is hinge-connected to a vehicle, a second gate of which an outside end portion is hinge-connected to the vehicle and configured to be rotated in a direction opposite to rotation of the first gate, and a center bar unit along a height direction of the vehicle on an inside end portion of the first gate, the center bar being configured to rotate in conjunction with opening or closing the first gate.

Abstract: An embodiment integrated operating apparatus for different types of gates includes a driving motor, a main shaft rotatable by the driving motor, a first clutch portion at a first side of the main shaft and configured to selectively transmit power to a first gate of a vehicle, the first clutch portion including a first clutch and a first gear selectively engaged with each other, and a second clutch portion at a second side of the main shaft and configured to selectively transmit power to a second gate of the vehicle, the second clutch portion including a second clutch and a second gear selectively engaged with each other, wherein the first and second gates are configured to be independently operated based on the first clutch portion being in an engaged state or a released state and the second clutch portion being in the engaged state or the released state.

Abstract: The present disclosure relates to an isolated anti-FcRN antibody, which is an antibody binding to FcRN (stands for neonatal Fc receptor, also called FcRP, FcRB or Brambell receptor) that is a receptor with a high affinity for IgG or a fragment thereof, a method of preparing thereof, a composition for treating autoimmune disease, which comprises the antibody, and a method of treating and diagnosing autoimmunre diseases using the antibody. The FcRn-specific antibody according to the present disclosure binds to FcRn non-competitively with IgG to reduce serum pathogenic auto-antibody levels, and thus can be used for the treatment of autoimmune diseases.

Abstract: A bone grafting material composite is provided. The bone grafting material composite includes a demineralized bone matrix (DBM) and a carboxymethyl cellulose (CMC)/glycerol gel carrier. Due to the CMC/glycerol gel carrier, the implantation ability thereof is better than that of the DBM. Therefore, the bone grafting material composite can be easily used, so that a curative effect can be greatly improved. In addition, since the CMC/glycerol gel is used as a carrier, the composite with a mobility maintained is washed out by water after surgery, so that the composite can be fixed on a damaged portion of a bone.

Abstract: A bone grafting material composite is provided. The bone grafting material composite includes a demineralized bone matrix (DBM) and a carboxymethyl cellulose (CMC)/glycerol gel carrier. Due to the CMC/glycerol gel carrier, the implantation ability thereof is better than that of the DBM. Therefore, the bone grafting material composite can be easily used, so that a curative effect can be greatly improved. In addition, since the CMC/glycerol gel is used as a carrier, the composite with a mobility maintained is washed out by water after surgery, so that the composite can be fixed on a damaged portion of a bone.

Abstract: A method is provided for producing a virus-inactivated, acellular implant for the human body, featuring the use of TNBP in combination with a detergent selected from among deoxycholate, SDS, Tween 80, Triton X-100, sodium cholate and combinations thereof for removing cells and viruses simultaneously. Also disclosed are an acellular human body implant produced by the method and a wound healing agent comprising the acellular human body implant.